检索结果-内蒙古大学图书馆

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

Journal of translational medicine 2016年第1期14卷 65页

作者： Vashisht G. Y. Nanda Weiyi Peng Patrick Hwu Michael A. Davies Gennaro Ciliberto Luigi Fattore Debora Malpicci Luigi Aurisicchio Paolo Antonio Ascierto Carlo M. Croce Rita Mancini Stefani Spranger Thomas F. Gajewski Yangyang Wang Soldano Ferrone Claire Vanpouille-Box Erik Wennerberg Karsten A. Pilones Silvia C. Formenti Sandra Demaria Haidong Tang Yang Wang Yang-Xin Fu Reinhard Dummer Igor Puzanov Ahmad Tarhini Joe-Marc Chauvin Ornella Pagliano Julien Fourcade Zhaojun Sun Hong Wang Cindy Sanders John M. Kirkwood Tseng-hui Timothy Chen Mark Maurer Alan J. Korman Hassane M. Zarour David F. Stroncek Veronica Huber Licia Rivoltini Magdalena Thurin Tilman Rau Alessandro Lugli Franck Pagès Jorge Camarero Arantxa Sancho Claudio Jommi Yago Pico de Coaña Maria Wolodarski Yuya Yoshimoto Giusy Gentilcore Isabel Poschke Giuseppe V. Masucci Johan Hansson Rolf Kiessling Giosuè Scognamiglio Francesco Sabbatino Federica Zito Marino Anna Maria Anniciello Monica Cantile Margherita Cerrone Stefania Scala Crescenzo D’alterio Angela Ianaro Giuseppe Cirin Giuseppina Liguori Gerardo Bott Paul B. Chapman Caroline Robert James Larkin John B. Haanen Antoni Ribas David Hogg Omid Hamid Alessandro Testori Paul Lorigan Jeffrey A. Sosman Keith T. Flaherty Huibin Yue Shelley Coleman Ivor Caro Axel Hauschild Grant A. McArthur Mario Sznol Margaret K. Callahan Harriet Kluger Michael A. Postow RuthAnn Gordan Neil H. Segal Naiyer A. Rizvi Alexander Lesokhin Michael B. Atkins Matthew M. Burke Amanda Ralabate Angel Rivera Stephanie A. Kronenberg Blessing Agunwamba Mary Ruisi Christine Horak Joel Jiang Jedd Wolchok Paolo A. Ascierto Gabriella Liszkay Michele Maio Mario Mandalà Lev Demidov Daniil Stoyakovskiy Luc Thomas Luis de la Cruz-Merino Victoria Atkinson Caroline Dutriaux Claus Garbe Matthew Wongchenko Ilsung Chang Daniel O. Koralek Isabelle Rooney Yibing Yan Brigitte Dréno Ryan Sullivan Manish Patel Stephen Hodi Rodabe Amaria Peter Boasberg Jeffrey Wallin Xian He Edward Cha Nicole Richie Marcus Ballinger David C. Smith Todd M. Bauer Jeffrey S. Was Department of Melanoma Medical Oncology University of Texas MD Anderson Cancer Center Houston USA The University of Texas MD Anderson Cancer Center Houston USA Istituto Nazionale per lo Studio e la Cura dei Tumori “Fondazione G. Pascale” Naples Italy IRCCS Istituto Nazionale Tumori de “Fondazione G. Pascale” Naples Italy Dipartimento di Medicina Sperimentale e Clinica Università degli Studi di Catanzaro “Magna Graecia” Catanzaro Italy Takis s.r.l. Rome Italy Unit of Medical Oncology and Innovative Therapy Istituto Nazionale per lo Studio e la Cura Tumori Fondazione “G. Pascale” Napoli Italy Unit of Melanoma Cancer Immunotherapy and Innovative Therapy Istituto Nazionale Tumori Fondazione Pascale Naples Italy IRCCS Istituto Nazionale Tumori “Fondazione G. Pascale” Naples Italy Department of Molecular Virology Immunology and Medical Genetics The Ohio State University Comprehensive Cancer Center Columbus USA Dipartimento di Chirurgia “P. Valdoni” Sapienza Università di Roma Rome Italy Dipartimento di Medicina Clinica e Molecolare Sapienza Università di Roma Rome Italy Department of Pathology University of Chicago Chicago USA Department of Medicine University of Chicago Chicago USA Department of Pathology and Department of Medicine-Section of Hematology/Oncology University of Chicago Chicago USA The University of Chicago Medicine Chicago USA Department of Surgery Massachusetts General Hospital Harvard Medical School Boston USA Department of Pathology NYU School of Medicine New York USA Department of Radiation Oncology NYU School of Medicine New York USA Department of Radiation Oncology Weill Cornell Medical College New York USA Department of Pathology University of Texas Southwestern Dallas USA Department of Dermatology University of Zurich Hospital Zurich Switzerland Dermatologische Klinik University of Zurich Zurich Switzerland University Hospital of Zurich Zurich Switzerland Universitaets Spital Zurich Switzerland Vanderbilt-Ingram Cancer Center

MELANOMA BRIDGE 2015 KEYNOTE SPEAKER PRESENTATIONS Molecular and immuno-advances K1 Immunologic and metabolic consequences of PI3K/AKT/mTOR activation in melanoma Vashisht G. Y. Nanda, Weiyi Peng, Patrick Hwu, Michael A. Davies K2 Non-mutational adaptive changes in melanoma cells exposed to BRAF and MEK inhibitors help the establishment of drug resistance Gennaro Ciliberto, Luigi Fattore, Debora Malpicci, Luigi Aurisicchio, Paolo Antonio Ascierto, Carlo M. Croce, Rita Mancini K3 Tumor-intrinsic beta-catenin signaling mediates tumor-immune avoidance Stefani Spranger, Thomas F. Gajewski K4 Intracellular tumor antigens as a source of targets of antibody-based immunotherapy of melanoma Yangyang Wang, Soldano Ferrone Combination therapies K5 Harnessing radiotherapy to improve responses to immunotherapy in cancer Claire Vanpouille-Box, Erik Wennerberg, Karsten A. Pilones, Silvia C. Formenti, Sandra Demaria K6 Creating a T cell-inflamed tumor microenvironment overcomes resistance to checkpoint blockade Haidong Tang, Yang Wang, Yang-Xin Fu K7 Biomarkers for treatment decisions? Reinhard Dummer K8 Combining oncolytic therapies in the era of checkpoint inhibitors Igor Puzanov K9 Immune checkpoint blockade for melanoma: should we combine or sequence ipilimumab and PD-1 antibody therapy? Michael A. Postow News in immunotherapy K10 An update on adjuvant and neoadjuvant therapy for melanom Ahmad Tarhini K11 Targeting multiple inhibitory receptors in melanoma Joe-Marc Chauvin, Ornella Pagliano, Julien Fourcade, Zhaojun Sun, Hong Wang, Cindy Sanders, John M. Kirkwood, Tseng-hui Timothy Chen, Mark Maurer, Alan J. Korman, Hassane M. Zarour K12 Improving adoptive immune therapy using genetically engineered T cells David F. Stroncek Tumor microenvironment and biomarkers K13 Myeloid cells and tumor exosomes: a crosstalk for assessing immunosuppression? Veronica Huber, Licia Rivoltini K14 Update on the SITC biomarker taskforce: progress and challenges Magdalena Thurin World-wide immunosc

关键词： Melanoma Overall Survival Melanoma Cell Melanoma Patient Melanoma Cell Line

来源：评论

学校读者我要写书评

暂无评论

Average effect estimation with dichotomized events when the missing data mechanism is not missing at random

引用

Open Access Medical Statistics 2012年 2卷 85页

作者： Amy M Kwon Dianxu Ren 1 Biostatistics and Bioinformatics Core James Graham Brown Cancer Center University of Louisville Louisville KY 2 Department of Biostatistics University of Pittsburgh Center for Research and Evaluation School of Nursing University of Pittsburgh Pittsburgh PA USA

Background:The purpose of this work was to estimate the average effect of the covariate of interest when the outcome variable is dichotomized from a continuous variable and data are incomplete, with the missing data not missing at random (NMAR). The motivating example is to estimating the effect of vitamin D levels on secondary hyperparathyroidism among patients with chronic kidney ***:The average effect of the covariate of interest is computed by a two-step procedure. In the first step, we identify the conditional distribution of the original variable given the covariates by obtaining the parameter estimates. In the second step, we draw the predictive values from the identified distribution, and create binary values from the predictive values by dichotomizing them at the ***:According to the simulation results, the biases of the effects between logistic regression with the complete data and the estimated logistic regression with the converted binary variable are negligible. For the application example, the effect of vitamin D on the occurrence of secondary hyperparathyroidism is highly significant in the complete case analysis, but only a modest effect of vitamin D on secondary hyperparathyroidism is observed under the NMAR ***:It is impossible to find consistent estimates without knowing the exact nature of the missing data when the missing data mechanism is NMAR. Also, the outcome variable is binary, so we may be faced with an unidentifiability problem when the missing data mechanism is NMAR. To avoid this problem, we estimated the average effect of the covariate of interest in the framework of a generalized linear model from the relationship between a dichotomized outcome and a continuous original outcome, and the estimated effect showed negligible bias according to this simulation.

关键词： average effect NMAR not missing at random dichotomized events secondary hyperparathyroidism

来源：评论

学校读者我要写书评

暂无评论

Allogeneic Hematopoietic Cell Transplantation Is Effective In Patients With Advanced Systemic Mastocytosis: A Multicenter Retrospective Analysis

引用

BLOOD 2013年第21期122卷 2145-2145页

作者： Ustun, Celalettin Reiter, Andreas Scott, Bart L. Nakamura, Ryotaro Gandhi, Damaj Kreil, Sebastian Shanley, Ryan Hogan, William J. Perales, Miguel-Angel Shore, Tsiporah B. Baurmann, Herrad Stuart, Robert K. Gruhn, Bernd Doubek, Michael Hsu, Jack W. Tholouli, Eleni Gromke, Tanja Godley, Lucy A. Pagano, Livio Gilman, Andrew Wagner, Eva Maria Shwayder, Tor Bornhaeuser, Martin Papadopoulos, Esperanza B. Boehm, Alexandra Vercellotti, Gregory M. Van Lint, Maria Theresa Schmid, Christoph Rabitsch, Werner Pullarkat, Vinod Barrett, A. John Hermine, Olivier Hagglund, Hans Gustaf Sperr, Wolfgang R. Popat, Uday R. Devine, Steven M. Deeg, H. Joachim Weisdorf, Daniel J. Akin, Cem Valent, Peter Hematology Oncology and Transplantation University of Minnesota Minneapolis MN USA III. Medizinische Universitätsklinik Medizinische Fakultät Mannheim der Universität Heidelberg Mannheim Germany Clinical Research Division Fred Hutchinson Cancer Research Center Seattle WA USA Hematology and Hematopoietic Cell Transplantation City of Hope National Medical Center Duarte CA USA Service d'hematologie Hopital Necker Enfants Malades Paris France Biostatistics and Bioinformatics Core University of Minnesota Masonic Cancer Center Minneapolis MN USA Division of Hematology Mayo Clinic Rochester MN USA Department of Medicine Adult Bone Marrow Transplantation Memorial Sloan-Kettering Cancer Center New York NY USA Divison of Hematology/Oncology Weill Cornell Medical College New York Presbyterian Hospital New York NY USA Stiftung Deutsche Klinik fuer Diagnostik GmbH Wiesbaden Germany Division of Hematology/ Oncology Medical University of South Carolina Charleston SC USA Department of Pediatrics Jena University Hospital Jena Germany Department of Internal Medicine Hematology and Oncology University Hospital Brno Masaryk University Brno Czech Republic Division of Hematology-Oncology University of Florida Gainesville FL USA Department of Paediatric Haematology Royal Manchester Children's Hospital Manchester United Kingdom Department of Bone Marrow Transplantation University Hospitals of Essen Essen Germany Section of Hematology/Oncology The University of Chicago Chicago IL USA Istituto di Ematologia Università Cattolica S. Cuore Rome Italy Pediatric Blood and Marrow Transplantation Levine Children's Hospital Charlotte NC USA Department of Internal Medicine I Division of Hematology and Hemostaseology Medical University of Vienna Vienna Austria

2145

关键词：

来源：评论

学校读者我要写书评

暂无评论

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016

引用

J Immunother Cancer 2016年第SUPPL 1期4卷 1-1页

作者： Andreas Lundqvist Vincent van Hoef Xiaonan Zhang Erik Wennerberg Julie Lorent Kristina Witt Laia Masvidal Sanz Shuo Liang Shannon Murray Ola Larsson Rolf Kiessling Yumeng Mao John-William Sidhom Catherine A. Bessell Jonathan Havel Jonathan Schneck Timothy A. Chan Eliot Sachsenmeier David Woods Anders Berglund Rupal Ramakrishnan Andressa Sodre Jeffrey Weber Roberta Zappasodi Yanyun Li Jingjing Qi Philip Wong Cynthia Sirard Michael Postow Walter Newman Henry Koon Vamsidhar Velcheti Margaret K. Callahan Jedd D. Wolchok Taha Merghoub Lawrence G. Lum Minsig Choi Archana Thakur Abhinav Deol Gregory Dyson Anthony Shields Cara Haymaker Marc Uemura Ravi Murthy Marihella James Daqing Wang Julie Brevard Catherine Monaghan Suzanne Swann James Geib Mark Cornfeld Srinivas Chunduru Sudhir Agrawal Cassian Yee Jennifer Wargo Sapna P. Patel Rodabe Amaria Hussein Tawbi Isabella Glitza Scott Woodman Wen-Jen Hwu Michael A. Davies Patrick Hwu Willem W. Overwijk Chantale Bernatchez Adi Diab Erminia Massarelli Neil H. Segal Vincent Ribrag Ignacio Melero Tara C. Gangadhar Walter Urba Dirk Schadendorf Robert L. Ferris Roch Houot Franck Morschhauser Theodore Logan Jason J. Luke William Sharfman Fabrice Barlesi Patrick A. Ott Laura Mansi Shivaani Kummar Gilles Salles Cecilia Carpio Roland Meier Suba Krishnan Dan McDonald Matthew Maurer Xuemin Gu Jaclyn Neely Satyendra Suryawanshi Ronald Levy Nikhil Khushalani Jennifer Wu Jinyu Zhang Fahmin Basher Mark Rubinstein Mark Bucsek Guanxi Qiao Cameron MacDonald Bonnie Hylander Elizabeth Repasky Shilpak Chatterjee Anusara Daenthanasanmak Paramita Chakraborty Kyle Toth Megan Meek Elizabeth Garrett-Mayer Michael Nishimura Chrystal Paulos Craig Beeson Xuezhong Yu Shikhar Mehrotra Fei Zhao Kathy Evans Christine Xiao Alisha Holtzhausen Brent A. Hanks Nicole Scharping Ashley V. Menk Rebecca Moreci Ryan Whetstone Rebekah Dadey Simon Watkins Robert Ferris Greg M. Delgoffe Jonathan Peled Sean Devlin Anna Staffas Melissa Lumish Kori Porosnicu Rodriguez Katya Ahr Miguel Perales Sergio Giralt Ying Taur Eric Pam Karolinska Institutet Stockholm Stockholms Lan Sweden Weill Cornell Medical College New York NY USA Nova Southeastern University Cell Therapy Institute Fort Lauderdale FL USA Johns Hopkins University School of Medicine Baltimore MD USA Immunology Program Johns Hopkins University School of Medicine Columbia MD USA Memorial Sloan Kettering Cancer Center New York NY USA Johns Hopkins Medical Institute Baltimore MD USA University of Rochester Monrovia MD USA NYU Langone Medical Center New York NY USA H. Lee Moffitt Cancer Center Tampa FL USA Ludwig Collaborative Laboratory Memorial Sloan Kettering Cancer Center New York NY USA Immune Monitoring Core Facility Memorial Sloan Kettering Cancer Center New York NY USA Leap Therapeutics Cambridge MA USA Department of Medicine Memorial Sloan Kettering Cancer Center New York NY USA Case Western Reserve University Cleveland OH USA Cleveland Clinic Main Campus Cleveland OH USA University of Virginia Cancer Center Charlottesville VA USA Stony Brook University Medical Center Stony Brook NY USA Karmanos Cancer Institute Detroit MI USA University of Texas MD Anderson Cancer Center Houston TX USA Idera Pharmaceuticals Inc. Cambridge MA USA Institut Gustave Roussy Villejuif Ile-de-France France Center for Applied Medical Research (CIMA) University of Navarra Pamplona Navarra Spain University of Pennsylvania Philadelphia PA USA Earle A. Chiles Research Institute Providence Cancer Center Portland OR USA Universitätsklinikum Essen Essen Nordrhein-Westfalen Germany University of Pittsburgh Pittsburgh PA USA CHU Rennes Service Hématologie Clinique and INSERM 0203 Unité d’Investigation Clinique Rennes Bretagne France Centre Hospitalier Régional Universitaire de Lille Lille Nord-Pas-de-Calais France Simon Cancer Center Indiana University Indianapolis IN USA University of Chicago School of Medicine Chicago IL USA Johns Hopkins University School of Medicine Lutherville MD USA Multidisciplinary Oncology and Therapeuti

来源：评论

学校读者我要写书评

暂无评论

P44—Toxicogenomic profiling of perfluorononanoic acid in wild-type and PPARα-null mice

引用

Reproductive Toxicology 2012年第4期33卷 614-614页

作者： M.B. Rosen J.R. Schmid R.D. Zehr K.P. Das H. Ren B.D. Abbott C. Lau Integrated Systems Biology Research Triangle Park NC United States Biostatistics and Bioinformatics Research Triangle Park NC United States Toxicology Assessment Research Triangle Park NC United States Toxicogenomics Core NHEERL ORD U.S. EPA Research Triangle Park NC United States

来源：评论

学校读者我要写书评

暂无评论

Proceedings of the 8th Annual Conference on the Science of Dissemination and Implementation : Washington, DC, USA. 14-15 December 2015

引用

Implementation science : IS 2016年第2期11 Suppl 2卷 100页

作者： Chambers, David Simpson, Lisa Hill-Briggs, Felicia Neta, Gila Vinson, Cynthia Beidas, Rinad Marcus, Steven Aarons, Gregory Hoagwood, Kimberly Schoenwald, Sonja Evans, Arthur Hurford, Matthew Rubin, Ronnie Hadley, Trevor Barg, Frances Walsh, Lucia Adams, Danielle Mandell, David Martin, Lindsey Mignogna, Joseph Mott, Juliette Hundt, Natalie Kauth, Michael Kunik, Mark Naik, Aanand Cully, Jeffrey McGuire, Alan White, Dominique Bartholomew, Tom McGrew, John Luther, Lauren Rollins, Angie Salyers, Michelle Cooper, Brittany Funaiole, Angie Richards, Julie Lee, Amy Lapham, Gwen Caldeiro, Ryan Lozano, Paula Gildred, Tory Achtmeyer, Carol Ludman, Evette Addis, Megan Marx, Larry Bradley, Katharine VanDeinse, Tonya Wilson, Amy Blank Stacey, Burgin Powell, Byron Bunger, Alicia Cuddeback, Gary Barnett, Miya Stadnick, Nicole Brookman-Frazee, Lauren Lau, Anna Dorsey, Shannon Pullmann, Michael Mitchell, Shannon Schwartz, Robert Kirk, Arethusa Dusek, Kristi Oros, Marla Hosler, Colleen Gryczynski, Jan Barbosa, Carolina Dunlap, Laura Lounsbury, David O’Grady, Kevin Brown, Barry Damschroder, Laura Waltz, Thomas Ritchie, Mona Atkins, David Imel, Zac E. Xiao, Bo Can, Doğan Georgiou, Panayiotis Narayanan, Shrikanth Berkel, Cady Gallo, Carlos Sandler, Irwin Brown, C. Hendricks Wolchik, Sharlene Mauricio, Anne Marie Mehrotra, Sanjay Chandurkar, Dharmendra Bora, Siddhartha Das, Arup Tripathi, Anand Saggurti, Niranjan Raj, Anita Hughes, Eric Jacobs, Brian Kirkendall, Eric Loeb, Danielle Trinkley, Katy Yang, Michael Sprowell, Andrew Nease, Donald Lyon, Aaron Lewis, Cara Boyd, Meredith Melvin, Abigail Nicodimos, Semret Liu, Freda Jungbluth, Nathanial Flynn, Allen Landis-Lewis, Zach Sales, Anne Baloh, Jure Ward, Marcia Zhu, Xi Bennett, Ian Unutzer, Jurgen Mao, Johnny Proctor, Enola Vredevoogd, Mindy Chan, Ya-Fen Williams, Nathaniel Green, Phillip Bernstein, Steven Rosner, June-Marie DeWitt, Michelle Tetrault, Jeanette Dziura, James Hsiao, Allen Sussman, Scott O’Connor, Patrick Toll, Benjamin Jones, Michael Gassaway, Julie Tobin, Jonathan Zatzic Division of Cancer Control and Population Sciences National Cancer Institute National Institutes of Health Rockville USA AcademyHealth Washington USA Department of Medicine and Welch Center for Prevention Epidemiology and Clinical Research Johns Hopkins Medical Institutions Baltimore USA Psychiatry University of Pennsylvania Philadelphia USA Family Medicine and Community Health University of Pennsylvania Philadelphia USA School of Social Policy and Practice University of Pennsylvania Philadelphia USA Psychiatry UC San Diego La Jolla USA Child & Adolescent Psychiatry The Child Study Center at NYU Langone Medical Center New York NY New York USA Psychiatry and Behavioral Sciences MUSC Charleston USA DBHIDS City of Philadelphia Philadelphia USA CBH City of Philadelphia Philadelphia USA Psychiatry University of Pennsylvania Perelman School of Medicine Philadelphia USA Health Services Research & Development Department of Veterans Affairs & Baylor College of Medicine Houston USA Treatment Core Department of Veterans Affairs Waco USA National Center for PTSD Executive Division Department of Veterans Affairs White River Junction USA HSR&D HSR&D Center for Health Information and Communication Roudebush VA Medical Center Indianapolis USA Psychology Indiana University Purdue University Indianapolis Indianapolis USA Department of Psychiatric Rehabilitation and Counseling Rutgers University Newark USA Health Services Research & Development Richard L. Roudebush VAMC Indianapolis USA IUPUI Department of Psychology ACT Center of Indiana Indianapolis USA Human Development Washington State University Pullman USA Prevention Science Washington State University Pullman USA Group Health Research Institute Group Health Seattle USA Behavioral Health Services Group Health Seattle USA Preventive Care Group Health Seattle USA Health Services Research & Development Primary and Specialty Medical Care Service VA Puget Sound Seattle USA School of Social Work Un

A1 Introduction to the 8th Annual Conference on the Science of Dissemination and Implementation: Optimizing Personal and Population Health David Chambers, Lisa Simpson D1 Discussion forum: Population health D&I research Felicia Hill-Briggs D2 Discussion forum: Global health D&I research Gila Neta, Cynthia Vinson D3 Discussion forum: Precision medicine and D&I research David Chambers S1 Predictors of community therapists’ use of therapy techniques in a large public mental health system Rinad Beidas, Steven Marcus, Gregory Aarons, Kimberly Hoagwood, Sonja Schoenwald, Arthur Evans, Matthew Hurford, Ronnie Rubin, Trevor Hadley, Frances Barg, Lucia Walsh, Danielle Adams, David Mandell S2 Implementing brief cognitive behavioral therapy (CBT) in primary care: Clinicians' experiences from the field Lindsey Martin, Joseph Mignogna, Juliette Mott, Natalie Hundt, Michael Kauth, Mark Kunik, Aanand Naik, Jeffrey Cully S3 Clinician competence: Natural variation, factors affecting, and effect on patient outcomes Alan McGuire, Dominique White, Tom Bartholomew, John McGrew, Lauren Luther, Angie Rollins, Michelle Salyers S4 Exploring the multifaceted nature of sustainability in community-based prevention: A mixed-method approach Brittany Cooper, Angie Funaiole S5 Theory informed behavioral health integration in primary care: Mixed methods evaluation of the implementation of routine depression and alcohol screening and assessment Julie Richards, Amy Lee, Gwen Lapham, Ryan Caldeiro, Paula Lozano, Tory Gildred, Carol Achtmeyer, Evette Ludman, Megan Addis, Larry Marx, Katharine Bradley S6 Enhancing the evidence for specialty mental health probation through a hybrid efficacy and implementation study Tonya VanDeinse, Amy Blank Wilson, Burgin Stacey, Byron Powell, Alicia Bunger, Gary Cuddeback S7 Personalizing evidence-based child mental health care within a fiscally mandated policy reform Miya Barnett, Nicole Stadnick, Lauren Brookman-Frazee, Anna Lau S8 Leveraging an existing

关键词： Veteran Affair Motivational Interview Qualitative Comparative Analysis Community That Care Supplemental Nutrition Assistance Program

来源：评论

学校读者我要写书评

暂无评论

Abstracts from the 3rd International Genomic Medicine Conference (3rd IGMC 2015) : Jeddah, Kingdom of Saudi Arabia. 30 November - 3 December 2015

引用

BMC genomics 2016年第6期17 Suppl 6卷 487页

作者： Jerry W. Shay Noriko Homma Ruyun Zhou Muhammad Imran Naseer Adeel G. Chaudhary Mohammed Al-Qahtani Nobutaka Hirokawa Maryam Goudarzi Albert J. Fornace Saleh Baeesa Deema Hussain Mohammed Bangash Fahad Alghamdi Hans-Juergen Schulten Angel Carracedo Ishaq Khan Hanadi Qashqari Nawal Madkhali Mohamad Saka Kulvinder S. Saini Awatif Jamal Jaudah Al-Maghrabi Adel Abuzenadah Adeel Chaudhary Mohammed Al Qahtani Ghazi Damanhouri Heba Alkhatabi Anne Goodeve Laura Crookes Nikolas Niksic Nicholas Beauchamp Adel M. Abuzenadah Jim Vaught Bruce Budowle Mourad Assidi Abdelbaset Buhmeida Leena Merdad Sudhir Kumar Sayaka Miura Karen Gomez Mahmood Rasool Ahmed Rebai Sajjad Karim Hend F. Nour Eldin Heba Abusamra Elham M. Alhathli Nada Salem Mohammed H. Al-Qahtani Hossam Faheem Ashok Agarwa Eberhard Nieschlag Joachim Wistuba Oliver S. Damm Mohd A. Beg Taha A. Abdel-Meguid Hisham A. Mosli Osama S. Bajouh Serdar Coskun Muhammad Abu-Elmagd Ashraf Dallol Sahar Hakamy Wejdan Al-Qahtani Asia Al-Harbi Shireen Hussain Burak Ozkosem Rick DuBois Safia S. Messaoudi Maryam T. Dandana Touhami Mahjoub Wassim Y. Almawi S. Abdalla M. Nabil Al-Aama Asmaa Elzawahry Tsuyoshi Takahashi Sachiyo Mimaki Eisaku Furukawa Rie Nakatsuka Isao Kurosaka Takahiko Nishigaki Hiromi Nakamura Satoshi Serada Tetsuji Naka Seiichi Hirota Tatsuhiro Shibata Katsuya Tsuchihara Toshirou Nishida Mamoru Kato Sajid Mehmood Naeem Mahmood Ashraf Awais Asif Muhammad Bilal Malik Siddique Mehmood Aadil Hussain Qazi Mohammad Sajid Jamal Mughees Uddin Siddiqui Mohammad A. Alzohairy Mohammad A. Al Karaawi Taoufik Nedjadi Heba Al-Khattabi Adel Al-Ammari Ahmed Al-Sayyad Hédia Zitouni Nozha Raguema Marwa Ben Ali Wided Malah Raja Lfalah Wassim Almawi Mohammed Elanbari Andrey Ptitsyn Sana Mahjoub Rabeb El Ghali Bechir Achour Nidhal Ben Amor Brahim N’siri Hamid Morjani Esam Azhar Vera Chayeb Maryam Dendena Hedia Zitouni Khedija Zouari-Limayem Bassem Refaat Ahmed M. Ashshi Sarah A. Batwa Hazem Ramadan Amal Awad Ahmed Ateya Adel Galal Ahmed El-Shemi Ahmad Ashshi Mohammed Basalamah Youjin Na Cha University of Texas Southwestern Medical Center Dallas USA Department of Cell Biology and Anatomy Graduate School of Medicine the University of Tokyo Tokyo Japan Center of Excellence in Genomic Medicine Research King Abdulaziz University Jeddah Saudi Arabia Department of Biochemistry and Molecular & Cellular Biology Lombardi Comprehensive Cancer Center Georgetown University Washington USA Department of Oncology Lombardi Comprehensive Cancer Center Georgetown University Washington USA Department of Radiation Medicine Lombardi Comprehensive Cancer Center Georgetown University Washington USA Center of Excellence in Genomic Medicine Research (CEGMR) King Abdulaziz University Jeddah Kingdom of Saudi Arabia King Fahd Medical Research Centre King Abdulaziz University Jeddah Saudi Arabia Centre of Excellence in Genomic Medicine Research King Abdulaziz University Jeddah Saudi Arabia Sheffield Diagnostic Genetic Service Sheffield Children’s NHS Foundation Trust Western Bank Sheffield UK Center of Innovations in Personalized Medicine King Abdulaziz University Jeddah Saudi Arabia President ISBER Editor-in-Chief Biopreservation & Biobanking ᅟ USA Institute of Applied Genetics Department of Molecular and Medical Genetics University of North Texas Health Science Center Fort Worth USA Department of Dental Public Health Faculty of Dentistry King Abdulaziz University Jeddah Saudi Arabia Institute for Genomics and Evolutionary Medicine Temple University Philadelphia USA Center of Excellence in Genomic Medicine King Abdulaziz University Jeddah Kingdom of Saudi Arabia Laboratory of Molecular and Cellular Screening Processes (Bioinformatics Group) Centre of Biotechnology of Sfax Sfax Tunisia Fujitsu Technology Solutions International ᅟ ᅟ Case Western Reserve University School of Medicine and Lerner College of Medicine Cleveland Clinic Foundation Cleveland USA American Center for Reproductive Medicine Andrology Center Cleveland USA Center for Reproductive Medicine and

O1 Regulation of genes by telomere length over long distances Jerry W. Shay O2 The microtubule destabilizer KIF2A regulates the postnatal establishment of neuronal circuits in addition to prenatal cell survival, cell migration, and axon elongation, and its loss leading to malformation of cortical development and severe epilepsy Noriko Homma, Ruyun Zhou, Muhammad Imran Naseer, Adeel G. Chaudhary, Mohammed Al-Qahtani, Nobutaka Hirokawa O3 Integration of metagenomics and metabolomics in gut microbiome research Maryam Goudarzi, Albert J. Fornace Jr. O4 A unique integrated system to discern pathogenesis of central nervous system tumors Saleh Baeesa, Deema Hussain, Mohammed Bangash, Fahad Alghamdi, Hans-Juergen Schulten, Angel Carracedo, Ishaq Khan, Hanadi Qashqari, Nawal Madkhali, Mohamad Saka, Kulvinder S. Saini, Awatif Jamal, Jaudah Al-Maghrabi, Adel Abuzenadah, Adeel Chaudhary, Mohammed Al Qahtani, Ghazi Damanhouri O5 RPL27A is a target of miR-595 and deficiency contributes to ribosomal dysgenesis Heba Alkhatabi O6 Next generation DNA sequencing panels for haemostatic and platelet disorders and for Fanconi anaemia in routine diagnostic service Anne Goodeve, Laura Crookes, Nikolas Niksic, Nicholas Beauchamp O7 Targeted sequencing panels and their utilization in personalized medicine Adel M. Abuzenadah O8 International biobanking in the era of precision medicine Jim Vaught O9 Biobank and biodata for clinical and forensic applications Bruce Budowle, Mourad Assidi, Abdelbaset Buhmeida O10 Tissue microarray technique: a powerful adjunct tool for molecular profiling of solid tumors Jaudah Al-Maghrabi O11 The CEGMR biobanking unit: achievements, challenges and future plans Abdelbaset Buhmeida, Mourad Assidi, Leena Merdad O12 Phylomedicine of tumors Sudhir Kumar, Sayaka Miura, Karen Gomez O13 Clinical implementation of pharmacogenomics for colorectal cancer treatment Angel Carracedo, Mahmood Rasool O14 From association to causality: translation of GWAS findings for genomic me

关键词：

来源：评论

学校读者我要写书评

暂无评论

Cardiac QTc Interval Characteristics and Behavior in 995 Consecutive Hematopoietic Cell Transplantation Patients At a Single Institution

引用

Blood 2011年第21期118卷 1967-1967页

作者： Weston P Miller IV Ryan Shanley Parvin Dorostkar Department of Pediatrics Division of Blood and Marrow Transplantation University of Minnesota Minneapolis MN USA Biostatistics and Bioinformatics Core University of Minnesota Masonic Cancer Center Department of Pediatrics Division of Cardiology University of Minnesota Minneapolis MN

Abstract 1967 Introduction: The cardiac QT interval (QT) has gained deserved scrutiny among electrophysiologists. Reflecting the duration of the ventricular myocardial depolarization/repolarization cycle, the QT depends upon ion exchange across cardiomyocyte membranes. Ion flux perturbations (due to abnormalities of membrane-bound ion channel number, structure or function) can predispose to QT prolongation that, in turn, is associated with linearly increasing risks of ventricular tachy-arrhythmias and sudden death. As both polypharmacy and dys-electrolytemia have been reported to affect QT, we studied the interval's behavior in the potentially at-risk population of children and adults undergoing hematopoietic cell transplantation (HCT). Methods: We retrospectively reviewed over 2600 cardiologist-evaluated electrocardiograms (ECG) and transplant-related data for 995 consecutive children and adults undergoing HCT between 2006 and 2010, inclusive. Patients underwent routine pre-HCT ECG screening; repeat studies were obtained for various clinical indications. Corrected QT intervals (QTc) were noted; any study demonstrating non-sinus rhythm was disregarded. Multivariate regression models tested the association between QTc and other patient or transplant-related covariates (including age, gender, primary diagnosis, intensity of conditioning, and donor relatedness/graft-versus host disease prophylaxis for allograft recipients); reference groups representing fixed covariate characteristics were defined among the cohort for comparison. Student's t-test was used to determine the significance of aggregate intra-patient change in QTc from pre- to post-HCT. Results: Pre-HCT: 952 patients had an evaluable pre-HCT maximum QTc observed at a median Day −22. Median QTc was 428 ms (range, 330 to 569; interquartile range [IQR], 409 to 447). Statistically significant QTc variability with age was observed and reflected widely accepted age-dependent phenomena in the population-at-large. F

关键词：

来源：评论

学校读者我要写书评

暂无评论

Comparison of triple negative breast cancer between Asian and western data sets

Comparison of triple negative breast cancer between Asian an...

引用

IEEE International Conference on bioinformatics and Biomedicine Workshops (BIBMW)

作者： Lee H. Chen Liang-Chuan Lai Chuhsing K. Hsiao Pei-Chun Chen Mong-Hsun Tsai Wen-Hung Kuo King-Jen Chang Eric Y. Chuang Bioinformatics and Biostatistics Core Research Center for Medical Excellence National Taiwan University Taiwan Institute of Biotechnology National Taiwan University Taiwan Graduate Institute of Physiology National Taiwan University Taiwan Department of Surgery National Taiwan University Hospital Taiwan Department of Public Health Institute of Epidemiology & Research Center for Gene Environment and Human Health National Taiwan University Taiwan Graduate Institute of Biomedical Electronics and Bioinformatics National Taiwan University Taiwan

The prognosis of triple negative breast cancer remains poor compared with other subtypes of breast cancer, such as hormone receptor positive or human epidermal growth factor receptor 2 positive breast cancers, for the application of possible adjuvant therapy of hormone therapy for hormone receptor positive breast cancer and target therapy for human epidermal growth factor receptor 2 positive breast cancers. Searching for adjuvant therapy for triple negative breast cancer is still the main goal for clinical practice. Moreover, it is believed the prognosis seems different between Asian and western people. Here, we focused on the signature of breast cancer to differentiate different races by comparing previous published literatures. By this method, obvious cluster of triple negative breast cancer formed, but minor clusters between Asian and western samples were also noted. The slight difference might be the first step to solve the dilemma of lacking treatment of triple negative breast cancer.

关键词： Breast cancer Gene expression Humans Medical treatment bioinformatics Erbium Breast tumors

来源：评论

学校读者我要写书评

暂无评论

A new regularized least squares support vector regression for gene selection

引用

BMC bioinformatics 2009年第1期10卷 1-11页

作者： Chen, Pei-Chun Huang, Su-Yun Chen, Wei J. Hsiao, Chuhsing K. Bioinformatics and Biostatistics Core Laboratory National Taiwan University Taipei Taiwan Institute of Statistical Science Academia Sinica Taipei Taiwan Department of Public Health National Taiwan University Taipei Taiwan Institute of Epidemiology National Taiwan University Taipei Taiwan

Background: Selection of influential genes with microarray data often faces the difficulties of a large number of genes and a relatively small group of subjects. In addition to the curse of dimensionality, many gene selection methods weight the contribution from each individual subject equally. This equal-contribution assumption cannot account for the possible dependence among subjects who associate similarly to the disease, and may restrict the selection of influential genes. Results: A novel approach to gene selection is proposed based on kernel similarities and kernel weights. We do not assume uniformity for subject contribution. Weights are calculated via regularized least squares support vector regression (RLS-SVR) of class levels on kernel similarities and are used to weight subject contribution. The cumulative sum of weighted expression levels are next ranked to select responsible genes. These procedures also work for multiclass classification. We demonstrate this algorithm on acute leukemia, colon cancer, small, round blue cell tumors of childhood, breast cancer, and lung cancer studies, using kernel Fisher discriminant analysis and support vector machines as classifiers. Other procedures are compared as well. Conclusion: This approach is easy to implement and fast in computation for both binary and multiclass problems. The gene set provided by the RLS-SVR weight-based approach contains a less number of genes, and achieves a higher accuracy than other procedures. © 2009 Chen et al;licensee BioMed Central Ltd.

关键词： Discriminant analysis

来源：评论

学校读者我要写书评

暂无评论

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

请选择保存的检索档案：

请选择收藏分类：

通借通还

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：